Delta and epsilon crystal forms of imatinib mesylate

Details for Australian Patent Application No. 2006283842 (hide)

Owner Novartis AG

Inventors Mutz, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2006283842

PCT Pub. Number WO2007/023182

Priority 60/711,738 26.08.05 US; 60/711,737 26.08.05 US; 60/712,206 29.08.05 US

Filing date 24 August 2006

Wipo publication date 1 March 2007

Acceptance publication date 17 March 2011

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/023182 Priority application(s): WO2007/023182

17 March 2011 Application Accepted

  Published as AU-B-2006283842

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283844-System for screening cells for high expression of a protein of interest (POI)

2006283821-Locomotive speed determination